Sensorium
Biotechnology · Health Care
$60.5Mtotal raised · 5 rounds on record
$26.8Mlatest round · Venture round · Jan 2025 · 21 mo ago
$2Mgrants · 2 grants · CORDIS
50+team · employees, estimated range
Overview
Clinical-stage biotech discovering novel CNS therapies from natural compounds validated by millennia of human use. Anxiety, epilepsy, Alzheimer's.
Funding and backers
Total raised
$60.5M
5 rounds on record
Latest round
$26.8M
Venture round · Jan 2025 · 21 mo ago
Team
51-200
employees, estimated range
Grants
$2M
2 grants · CORDIS
The money's age
Due for its next round
21 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 15, 2025
New executive Jacob Hooker, Executive Officer, Director · SEC Form D
Apr 5, 2025
Won a grant $1.5M · CORDIS
Feb 12, 2025
Board appointment David Southwell, Director · SEC Form D
Dec 1, 2023
Won a grant $502k · CORDIS
May 5, 2023
Launched Sensorium Unveils Sensorium Arc - A New Decentralized Platform for the Web3 Era · International Business Times
Nov 17, 2022
Partnership Sensorium Teams Up With Polygon Studios To Accelerate The Development And Adoption Of Web3 Projects · Nasdaq
Oct 4, 2022
Board appointment Kevin Lalande, Director · SEC Form D
Sep 19, 2022
Raised a round Venture round $24.7M · SEC Form D
Jul 8, 2021
Raised a round Venture round $9M · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Apr 2025 | $1.5M | — | CORDIS |
| Venture round | Jan 2025 | $26.8M | — | SEC Form D |
| Grant | Dec 2023 | $502k | — | CORDIS |
| Venture round | Sep 2022 | $24.7M | — | SEC Form D |
| Venture round | Jul 2021 | $9M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Sensorium Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Richard SimonDirectorSEC Form D
Pranav TadiExecutive OfficerSEC Form D
Alexandra GlucksmannDirectorSEC Form D
Jacob HookerExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Ottimo Pharma
backs NMD Pharma
Similar startupsby what they do, their industry and backers
Anodyne Nanotech is a clinical-stage biotech company, developing transdermal premium products for the treatment of chronic diseases.
Elevara Medicines is a clinical-stage biotech. ELV001 targets fibroblast-like synoviocytes and synergizes with DMARDs to achieve clinical…
ABOUT US CONNECTA Therapeutics S.L. is a clinical-stage biotech company pioneering first-in-class neuroplasticity modulators to address…
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through…
0 Enable better lives through novel therapies to restore skeletal muscle health About NMD Pharma NMD Pharma is a clinical-stage biotech…
Pincelli is a pre-clinical stage biotech company focused on the development of innovative first-in-class treatments for rare skin diseases.
People
Richard Simon
Director
Pranav Tadi
Executive Officer
Alexandra Glucksmann
Director
Jacob Hooker
Executive Officer, Director
Jerrold Rosenbaum
Director
Ryan Katz
Director
Kevin Lalande
Director
Balkrishan Gill
Director
David Southwell
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Sensorium Therapeutics to Present SNTX-2643 Mechanistic Data and Phase 1a Study Design at ASCP 2026
Read more
Report
World Sensorium 2025: A Formulaic Portrayal of Changing Populations and Conservation - World Sensorium / Conservancy
Read more
Report
World Sensorium: Crafting Action Today for a Better Tomorrow - World Sensorium / Conservancy
Read more
Report
World Sensorium: Mapping the Tangible and Intangible Cultural Heritage of Aromatic Plants - World Sensorium / Conservancy
Read more
Report
Sensorium Unveils Sensorium Arc - A New Decentralized Platform for the Web3 Era
Dubai, UAE, May 5th, 2023, Chainwire
Read more
Report
Sensorium Galaxy Enters Public Playtest and Lays Out Global Metaverse Vision
Zug, Switzerland--(Newsfile Corp. - February 22, 2023) - Sensorium is announcing the launch of Sensorium Galaxy
Read more
Report
Sensorium Teams Up With Polygon Studios To Accelerate The Development And Adoption Of Web3 Projects
Sensorium, the company behind the industry-leading Sensorium Galaxy metaverse, is pleased to announce that it is entering into a collaboration agreement with Polygon Studios. As part of this wide-ranging alliance, Polygon' s blockchain infrastructure will
Read more
Report
Report
The Imperial Sensorium
Tracing how our violent world was built by the paranoid 20th Century nuclear order and proponents of Cybernetics.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
50-200 est. staff